237 related articles for article (PubMed ID: 22918549)
41. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.
Wei JL; Jiang YZ; Shao ZM
Int J Clin Oncol; 2019 Aug; 24(8):934-940. PubMed ID: 30888527
[TBL] [Abstract][Full Text] [Related]
42. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
[TBL] [Abstract][Full Text] [Related]
43. Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status.
Lowry KP; Ichikawa L; Hubbard RA; Buist DSM; Bowles EJA; Henderson LM; Kerlikowske K; Specht JM; Sprague BL; Wernli KJ; Lee JM
Cancer; 2023 Apr; 129(8):1173-1182. PubMed ID: 36789739
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
45. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer.
Xie L; Bao X; Cai T; Silva SG; Ma J; Zhang Z; Guo X; Marks LB
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):275-284. PubMed ID: 31201893
[TBL] [Abstract][Full Text] [Related]
46. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Calip GS; Law EH; Ko NY
Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
[TBL] [Abstract][Full Text] [Related]
47. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
48. Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study.
Sundbøll J; Farkas DK; Adelborg K; Schapira L; Tamang S; Nørgaard M; Cullen MR; Cronin-Fenton D; Sørensen HT
Breast Cancer Res Treat; 2020 Dec; 184(3):825-837. PubMed ID: 32845432
[TBL] [Abstract][Full Text] [Related]
49. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Bassal M; Mertens AC; Taylor L; Neglia JP; Greffe BS; Hammond S; Ronckers CM; Friedman DL; Stovall M; Yasui YY; Robison LL; Meadows AT; Kadan-Lottick NS
J Clin Oncol; 2006 Jan; 24(3):476-83. PubMed ID: 16421424
[TBL] [Abstract][Full Text] [Related]
50. Concordance in histological and biological parameters between first and second primary breast cancers.
Huo D; Melkonian S; Rathouz PJ; Khramtsov A; Olopade OI
Cancer; 2011 Mar; 117(5):907-15. PubMed ID: 20945326
[TBL] [Abstract][Full Text] [Related]
51. Risk of contralateral second primary breast cancer according to hormone receptor status in Germany.
Rusner C; Wolf K; Bandemer-Greulich U; Engel J; Stegmaier C; Holleczek B; Schubert-Fritschle G; Tillack A; Stang A
Breast Cancer Res; 2014 Oct; 16(5):452. PubMed ID: 25277819
[TBL] [Abstract][Full Text] [Related]
52. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women.
Milano MT; Strawderman RL; Venigalla S; Ng K; Travis LB
J Thorac Oncol; 2014 Aug; 9(8):1081-90. PubMed ID: 25157761
[TBL] [Abstract][Full Text] [Related]
53. Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).
Molina-Montes E; Pollán M; Payer T; Molina E; Dávila-Arias C; Sánchez MJ
Gynecol Oncol; 2013 Aug; 130(2):340-5. PubMed ID: 23648471
[TBL] [Abstract][Full Text] [Related]
54. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.
Sandberg ME; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K
Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811
[TBL] [Abstract][Full Text] [Related]
55. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis.
Allen I; Hassan H; Sofianopoulou E; Eccles D; Turnbull C; Tischkowitz M; Pharoah P; Antoniou AC
Breast Cancer Res; 2023 Feb; 25(1):18. PubMed ID: 36765408
[TBL] [Abstract][Full Text] [Related]
56. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
57. The risk of contralateral breast cancer: a SEER-based analysis.
Giannakeas V; Lim DW; Narod SA
Br J Cancer; 2021 Aug; 125(4):601-610. PubMed ID: 34040177
[TBL] [Abstract][Full Text] [Related]
58. Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study.
Barclay ME; Lyratzopoulos G; Walter FM; Jefferies S; Peake MD; Rintoul RC
Thorax; 2019 May; 74(5):466-472. PubMed ID: 30777897
[TBL] [Abstract][Full Text] [Related]
59. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
[TBL] [Abstract][Full Text] [Related]
60. Lung cancer risk and radiation dose among women treated for breast cancer.
Inskip PD; Stovall M; Flannery JT
J Natl Cancer Inst; 1994 Jul; 86(13):983-8. PubMed ID: 8007020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
